United States Pharmaceuticals

Barrier Therapeutics Inc (BTRX)

Track

Track

Ticker: BTRX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Bengal Acquisition Inc. See Footnote (1) Large shareholder
Transaction date
Purchase
Price
437.84
Quantity 18,635 -32.0%
Value US$4,207,035
Stiefel Laboratories, Inc. See footnote (1)(2) Large shareholder
Transaction date
Purchase
Price
414.03
Quantity 75,410 -40.1%
Value US$3,672,996
ERICKSON EDWARD L Non-Executive Director
Transaction date
Purchase
Price
277.64
Quantity 70,382 -18.2%
Value US$4,387,336
ERICKSON EDWARD L Non-Executive Director
Transaction date
Purchase
Price
7.26
Quantity 100 +11.1%
Value US$726
ERICKSON EDWARD L Non-Executive Director
Transaction date
Purchase
Price
7.25
Quantity 300 +50.0%
Value US$2,175
ERICKSON EDWARD L Non-Executive Director
Transaction date
Purchase
Price
7.23
Quantity 600 +inf%
Value US$4,338
Jacey Charles F Jr Non-Executive Director
Transaction date
Purchase
Price
6.40
Quantity 300 +100.0%
Value US$1,920
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.44
Quantity 1,000 +10.0%
Value US$5,437
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
5.44
Quantity 600 +0.1%
Value US$3,262
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.42
Quantity 400 +0.1%
Value US$2,168
CAMPBELL ROBERT E Non-Executive Director
Transaction date
Purchase
Price
5.92
Quantity 3,000 +100.0%
Value US$17,751
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
6.17
Quantity 4,000 +100.0%
Value US$24,680
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
6.17
Quantity 1,000 +0.2%
Value US$6,166
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
9.25
Quantity 1,300 +0.3%
Value US$12,022
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
9.25
Quantity 700 +0.1%
Value US$6,475
CAMPBELL ROBERT E Non-Executive Director
Transaction date
Purchase
Price
9.97
Quantity 1,000 +50.0%
Value US$9,970
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
14.47
Quantity 200 +5.3%
Value US$2,894
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
14.34
Quantity 1,300 +52.0%
Value US$18,642
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
14.80
Quantity 100 +0.0%
Value US$1,480
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
14.79
Quantity 100 +0.0%
Value US$1,479
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
14.78
Quantity 100 +0.0%
Value US$1,478
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
14.77
Quantity 1,200 +0.2%
Value US$17,724
VANLENT ANNE Exec. V.P., CFO and Treasurer Officer
Transaction date
Planned purchase
Price
14.47
Quantity 2,000 +1.8%
Value US$28,930
SIMON NICHOLAS J III Non-Executive Director
Transaction date
Sale
Price
19.50
Quantity 384,236 -16.5%
Value US$7,492,602
EVNIN LUKE See Remarks
Transaction date
Sale
Price
19.50
Quantity 384,236 -16.5%
Value US$7,492,602
MPM BIOVENTURES III QP LP See Remarks
Transaction date
Sale
Price
19.50
Quantity 384,236 -16.5%
Value US$7,492,602
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Sale
Price
18.33
Quantity 380,497 -16.4%
Value US$6,974,510
JP MORGAN PARTNERS BHCA LP Large shareholder
Transaction date
Sale
Price
18.33
Quantity 3,682 -16.4%
Value US$67,491
JP MORGAN PARTNERS BHCA LP Large shareholder
Transaction date
Sale
Price
18.33
Quantity 9,068 -16.4%
Value US$166,216
JP MORGAN PARTNERS BHCA LP Large shareholder
Transaction date
Sale
Price
18.33
Quantity 33,018 -16.4%
Value US$605,220
JP MORGAN PARTNERS BHCA LP Large shareholder
Transaction date
Sale
Price
18.33
Quantity 65,168 -16.4%
Value US$1,194,529
JP MORGAN PARTNERS BHCA LP Large shareholder
Transaction date
Sale
Price
18.33
Quantity 380,497 -16.4%
Value US$6,974,510
PERSEUS SOROS BIOPHARMACEUTICAL FUND LP See footnote (2)
Transaction date
Sale
Price
19.50
Quantity 430,004 -15.6%
Value US$8,385,078
JOHNSON & JOHNSON Large shareholder
Transaction date
Sale
Price
19.50
Quantity 694,327 -15.6%
Value US$13,539,376
JP MORGAN PARTNERS BHCA LP Large shareholder
Transaction date
Purchase
Price
7.94
Quantity 147,134 +inf%
Value US$1,168,244
JP MORGAN PARTNERS BHCA LP Large shareholder
Transaction date
Sale
Price
7.94
Quantity 147,134 -6.0%
Value US$1,168,244
BRISTOW ALBERT General Counsel and Secretary Officer
Transaction date
Planned sale
Price
16.25
Quantity 500 -85.0%
Value US$8,125
BRISTOW ALBERT General Counsel and Secretary Officer
Transaction date
Planned sale
Price
16.38
Quantity 500 -85.0%
Value US$8,190
BRISTOW ALBERT General Counsel and Secretary Officer
Transaction date
Planned sale
Price
16.35
Quantity 1,000 -63.0%
Value US$16,350
BRISTOW ALBERT General Counsel and Secretary Officer
Transaction date
Planned sale
Price
16.33
Quantity 500 -23.9%
Value US$8,165
BRISTOW ALBERT General Counsel and Secretary Officer
Transaction date
Planned sale
Price
16.32
Quantity 500 -19.3%
Value US$8,160
CAMPBELL ROBERT E Non-Executive Director
Transaction date
Purchase
Price
16.25
Quantity 2,000 +inf%
Value US$32,500
MPM BIOVENTURES III QP LP Large shareholder
Transaction date
Sale
Price
17.90
Quantity 10,000 -0.4%
Value US$179,001
SIMON NICHOLAS J III Non-Executive Director Large shareholder
Transaction date
Sale
Price
17.90
Quantity 10,000 -0.4%
Value US$179,001
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
17.90
Quantity 10,000 -0.4%
Value US$179,001
VANLENT ANNE Exec. V.P., CFO and Treasurer Officer
Transaction date
Purchase
Price
10.18
Quantity 1,000 +inf%
Value US$10,180
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
10.70
Quantity 1,500 +150.0%
Value US$16,050
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
10.16
Quantity 1,000 +0.2%
Value US$10,160
2.6
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
15.00
Quantity 1,000 +inf%
Value US$15,000
2.6
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
15.00
Quantity 1,000 +inf%
Value US$15,000
2.6
CAUWENBERGH GEERT Chief Executive Officer Executive Director
Transaction date
Purchase
Price
15.00
Quantity 1,000 +inf%
Value US$15,000
1.8
EVNIN LUKE Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 200,000 +9.3%
Value US$3,000,000
1.8
SIMON NICHOLAS J III Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 200,000 +9.3%
Value US$3,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-08-06 2008-08-06 B Purchase Bengal Acquisition Inc.

See Footnote (1)

Large shareholder
18,635 -32.0%
437.84
US$4,207,035 		18,635 -32.0% 437.84 US$4,207,035
2008-08-05 2008-08-05 B Purchase Stiefel Laboratories, Inc.

See footnote (1)(2)

Large shareholder
75,410 -40.1%
414.03
US$3,672,996 		75,410 -40.1% 414.03 US$3,672,996
2006-11-14 2006-11-13 B Purchase ERICKSON EDWARD L Non-Executive Director
70,382 -18.2%
277.64
US$4,387,336 		70,382 -18.2% 277.64 US$4,387,336
2006-11-14 2006-11-13 B Purchase ERICKSON EDWARD L Non-Executive Director
100 +11.1%
7.26
US$726 		100 +11.1% 7.26 US$726
2006-11-14 2006-11-13 B Purchase ERICKSON EDWARD L Non-Executive Director
300 +50.0%
7.25
US$2,175 		300 +50.0% 7.25 US$2,175
2006-11-14 2006-11-13 B Purchase ERICKSON EDWARD L Non-Executive Director
600 +inf%
7.23
US$4,338 		600 +inf% 7.23 US$4,338
2006-09-27 2006-09-27 B Purchase Jacey Charles F Jr Non-Executive Director
300 +100.0%
6.40
US$1,920 		300 +100.0% 6.40 US$1,920
2006-08-10 2006-08-09 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,000 +10.0%
5.44
US$5,437 		1,000 +10.0% 5.44 US$5,437
2006-08-10 2006-08-09 PP Planned purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
600 +0.1%
5.44
US$3,262 		600 +0.1% 5.44 US$3,262
2006-08-10 2006-08-09 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
400 +0.1%
5.42
US$2,168 		400 +0.1% 5.42 US$2,168
2006-06-16 2006-06-16 B Purchase CAMPBELL ROBERT E Non-Executive Director
3,000 +100.0%
5.92
US$17,751 		3,000 +100.0% 5.92 US$17,751
2006-05-19 2006-05-19 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
4,000 +100.0%
6.17
US$24,680 		4,000 +100.0% 6.17 US$24,680
2006-05-19 2006-05-19 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,000 +0.2%
6.17
US$6,166 		1,000 +0.2% 6.17 US$6,166
2006-03-15 2006-03-15 PP Planned purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,300 +0.3%
9.25
US$12,022 		1,300 +0.3% 9.25 US$12,022
2006-03-15 2006-03-15 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
700 +0.1%
9.25
US$6,475 		700 +0.1% 9.25 US$6,475
2006-03-06 2006-03-06 B Purchase CAMPBELL ROBERT E Non-Executive Director
1,000 +50.0%
9.97
US$9,970 		1,000 +50.0% 9.97 US$9,970
2005-03-14 2005-03-11 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
200 +5.3%
14.47
US$2,894 		200 +5.3% 14.47 US$2,894
2005-03-14 2005-03-11 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,300 +52.0%
14.34
US$18,642 		1,300 +52.0% 14.34 US$18,642
2005-03-14 2005-03-11 PP Planned purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
100 +0.0%
14.80
US$1,480 		100 +0.0% 14.80 US$1,480
2005-03-14 2005-03-11 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
100 +0.0%
14.79
US$1,479 		100 +0.0% 14.79 US$1,479
2005-03-14 2005-03-11 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
100 +0.0%
14.78
US$1,478 		100 +0.0% 14.78 US$1,478
2005-03-14 2005-03-11 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,200 +0.2%
14.77
US$17,724 		1,200 +0.2% 14.77 US$17,724
2005-03-09 2005-03-08 PP Planned purchase VANLENT ANNE

Exec. V.P., CFO and Treasurer

Officer
2,000 +1.8%
14.47
US$28,930 		2,000 +1.8% 14.47 US$28,930
2005-03-03 2005-02-15 S Sale SIMON NICHOLAS J III Non-Executive Director
384,236 -16.5%
19.50
US$7,492,602 		384,236 -16.5% 19.50 US$7,492,602
2005-03-03 2005-02-15 S Sale EVNIN LUKE

See Remarks
384,236 -16.5%
19.50
US$7,492,602 		384,236 -16.5% 19.50 US$7,492,602
2005-03-03 2005-02-15 S Sale MPM BIOVENTURES III QP LP

See Remarks
384,236 -16.5%
19.50
US$7,492,602 		384,236 -16.5% 19.50 US$7,492,602
2005-02-17 2005-02-15 S Sale AKKARAJU SRINIVAS Non-Executive Director
380,497 -16.4%
18.33
US$6,974,510 		380,497 -16.4% 18.33 US$6,974,510
2005-02-17 2005-02-15 S Sale JP MORGAN PARTNERS BHCA LP Large shareholder
3,682 -16.4%
18.33
US$67,491 		3,682 -16.4% 18.33 US$67,491
2005-02-17 2005-02-15 S Sale JP MORGAN PARTNERS BHCA LP Large shareholder
9,068 -16.4%
18.33
US$166,216 		9,068 -16.4% 18.33 US$166,216
2005-02-17 2005-02-15 S Sale JP MORGAN PARTNERS BHCA LP Large shareholder
33,018 -16.4%
18.33
US$605,220 		33,018 -16.4% 18.33 US$605,220
2005-02-17 2005-02-15 S Sale JP MORGAN PARTNERS BHCA LP Large shareholder
65,168 -16.4%
18.33
US$1,194,529 		65,168 -16.4% 18.33 US$1,194,529
2005-02-17 2005-02-15 S Sale JP MORGAN PARTNERS BHCA LP Large shareholder
380,497 -16.4%
18.33
US$6,974,510 		380,497 -16.4% 18.33 US$6,974,510
2005-02-17 2005-02-15 S Sale PERSEUS SOROS BIOPHARMACEUTICAL FUND LP

See footnote (2)
430,004 -15.6%
19.50
US$8,385,078 		430,004 -15.6% 19.50 US$8,385,078
2005-02-15 2005-02-15 S Sale JOHNSON & JOHNSON Large shareholder
694,327 -15.6%
19.50
US$13,539,376 		694,327 -15.6% 19.50 US$13,539,376
2005-01-04 2004-12-30 B Purchase JP MORGAN PARTNERS BHCA LP Large shareholder
147,134 +inf%
7.94
US$1,168,244 		147,134 +inf% 7.94 US$1,168,244
2005-01-04 2004-12-30 S Sale JP MORGAN PARTNERS BHCA LP Large shareholder
147,134 -6.0%
7.94
US$1,168,244 		147,134 -6.0% 7.94 US$1,168,244
2004-12-30 2004-12-30 PlS Planned sale BRISTOW ALBERT

General Counsel and Secretary

Officer
500 -85.0%
16.25
US$8,125 		500 -85.0% 16.25 US$8,125
2004-12-30 2004-12-29 PlS Planned sale BRISTOW ALBERT

General Counsel and Secretary

Officer
500 -85.0%
16.38
US$8,190 		500 -85.0% 16.38 US$8,190
2004-12-30 2004-12-29 PlS Planned sale BRISTOW ALBERT

General Counsel and Secretary

Officer
1,000 -63.0%
16.35
US$16,350 		1,000 -63.0% 16.35 US$16,350
2004-12-30 2004-12-29 PlS Planned sale BRISTOW ALBERT

General Counsel and Secretary

Officer
500 -23.9%
16.33
US$8,165 		500 -23.9% 16.33 US$8,165
2004-12-30 2004-12-29 PlS Planned sale BRISTOW ALBERT

General Counsel and Secretary

Officer
500 -19.3%
16.32
US$8,160 		500 -19.3% 16.32 US$8,160
2004-12-28 2004-12-28 B Purchase CAMPBELL ROBERT E Non-Executive Director
2,000 +inf%
16.25
US$32,500 		2,000 +inf% 16.25 US$32,500
2004-12-22 2004-12-20 S Sale MPM BIOVENTURES III QP LP Large shareholder
10,000 -0.4%
17.90
US$179,001 		10,000 -0.4% 17.90 US$179,001
2004-12-22 2004-12-20 S Sale SIMON NICHOLAS J III Non-Executive Director Large shareholder
10,000 -0.4%
17.90
US$179,001 		10,000 -0.4% 17.90 US$179,001
2004-12-22 2004-12-20 S Sale EVNIN LUKE Large shareholder
10,000 -0.4%
17.90
US$179,001 		10,000 -0.4% 17.90 US$179,001
2004-08-18 2004-08-17 B Purchase VANLENT ANNE

Exec. V.P., CFO and Treasurer

Officer
1,000 +inf%
10.18
US$10,180 		1,000 +inf% 10.18 US$10,180
2004-08-16 2004-08-13 B Purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,500 +150.0%
10.70
US$16,050 		1,500 +150.0% 10.70 US$16,050
2004-08-16 2004-08-13 PP Planned purchase CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,000 +0.2%
10.16
US$10,160 		1,000 +0.2% 10.16 US$10,160
2004-05-06 2004-05-04 B Purchase
2.6
CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,000 +inf%
15.00
US$15,000 		1,000 +inf% 15.00 US$15,000
2004-05-06 2004-05-04 B Purchase
2.6
CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,000 +inf%
15.00
US$15,000 		1,000 +inf% 15.00 US$15,000
2004-05-06 2004-05-04 B Purchase
2.6
CAUWENBERGH GEERT

Chief Executive Officer

Executive Director
1,000 +inf%
15.00
US$15,000 		1,000 +inf% 15.00 US$15,000
2004-05-05 2004-05-04 B Purchase
1.8
EVNIN LUKE
Large shareholder
200,000 +9.3%
15.00
US$3,000,000 		200,000 +9.3% 15.00 US$3,000,000
2004-05-05 2004-05-04 B Purchase
1.8
SIMON NICHOLAS J III
Large shareholder
200,000 +9.3%
15.00
US$3,000,000 		200,000 +9.3% 15.00 US$3,000,000
2004-05-05 2004-05-04 B Purchase
1.8
MPM BIOVENTURES III QP LP
Large shareholder
200,000 +9.3%
15.00
US$3,000,000 		200,000 +9.3% 15.00 US$3,000,000
Explore more

More insider trading research around Barrier Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America